{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:11:07Z","timestamp":1790705467986,"version":"4.1.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Parkinson\u2019s Progression Markers Initiative"},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"4D Pharma"},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AcureX"},{"DOI":"10.13039\/100030897","name":"Amathus Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AskBio"},{"DOI":"10.13039\/100014392","name":"Avid Radiopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bial Portela"},{"name":"BioArctic"},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biohaven"},{"name":"BioLegend"},{"name":"BlueRock Therapeutics"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Calico Labs"},{"name":"Capsida Biotherapeutics"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019850","name":"Cerevel Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019850","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coave Therapeutics"},{"name":"DaCapo Brainscience"},{"DOI":"10.13039\/100013162","name":"DENALI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Edmond J. Safra Foundation"},{"name":"Eli Lilly"},{"name":"Gain Therapeutics"},{"name":"General Electric HealthCare"},{"name":"Genentech, GlaxoSmithKline"},{"name":"Golub Capital"},{"name":"Handl Therapeutics"},{"name":"Insitro"},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Meso Scale Discovery"},{"name":"Mission Therapeutics"},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neuron23"},{"name":"Neuropore Therapies"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Piramal"},{"name":"Prevail Therapeutics"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sun Pharma Advanced Research Company"},{"DOI":"10.13039\/100007723","name":"Takeda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016879","name":"Union Chimique Belge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016879","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vanqua Bio"},{"DOI":"10.13039\/100018044","name":"Verily","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018044","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018556","name":"Voyager Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019889","name":"Weston Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019889","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yumanity Therapeutics"},{"name":"Intramural Research Program of the"},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Alzheimer\u2019s and Related Dementias","award":["AG000534"],"award-info":[{"award-number":["AG000534"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Among LRRK2-associated parkinsonism cases with nigral degeneration, over two-thirds demonstrate evidence of pathologic alpha-synuclein, but many do not. Understanding the clinical phenotype and underlying biology in such individuals is critical for therapeutic development. Our objective was to compare clinical and biomarker features, and rate of progression over 4 years of follow-up, among LRRK2-associated parkinsonism cases with and without in vivo evidence of alpha-synuclein aggregates. Data were from the Parkinson\u2019s Progression Markers Initiative, a multicentre prospective cohort study. The sample included individuals diagnosed with Parkinson disease with pathogenic variants in LRRK2. Presence of CSF alpha-synuclein aggregation was assessed with seed amplification assay. A range of clinician- and patient-reported outcome assessments were administered. Biomarkers included dopamine transporter scan, CSF amyloid-beta1-42, total tau, phospho-tau181, urine bis(monoacylglycerol)phosphate levels and serum neurofilament light chain. Linear mixed-effects (LMMs) models examined differences in trajectory in CSF-negative and CSF-positive groups. A total of 148 LRRK2 parkinsonism cases (86% with G2019S variant), 46 negative and 102 positive for CSF alpha-synuclein seed amplification assay, were included. At baseline, the negative group was older than the positive group [median (inter-quartile range) 69.1 (65.2\u201372.3) versus 61.5 (55.6\u201366.9) years, P &amp;lt; 0.001] and a greater proportion were female [28 (61%) versus 43 (42%), P = 0.035]. Despite being older, the negative group had similar duration since diagnosis and similar motor rating scale [16 (11\u201323) versus 16 (10\u201322), P = 0.480] though lower levodopa equivalents. Only 13 (29%) of the negative group were hyposmic, compared with 75 (77%) of the positive group. The negative group, compared with the positive group, had higher per cent-expected putamenal dopamine transporter binding for their age and sex [0.36 (0.29\u20130.45) versus 0.26 (0.22\u20130.37), P &amp;lt; 0.001]. Serum neurofilament light chain was higher in the negative group compared with the positive group [17.10 (13.60\u201322.10) versus 10.50 (8.43\u201314.70) pg\/mL; age-adjusted P-value = 0.013]. In terms of longitudinal change, the negative group remained stable in functional rating scale score in contrast to the positive group who had a significant increase (worsening) of 0.729 per year (P = 0.037), but no other differences in trajectory were found. Among individuals diagnosed with Parkinson disease with pathogenic variants in the LRRK2 gene, we found clinical and biomarker differences in cases without versus with in vivo evidence of CSF alpha-synuclein aggregates. LRRK2 parkinsonism cases without evidence of alpha-synuclein aggregates as a group exhibit less severe motor manifestations and decline. The underlying biology in LRRK2 parkinsonism cases without evidence of alpha-synuclein aggregates requires further investigation.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaf103","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:24:58Z","timestamp":1741188298000},"source":"Crossref","is-referenced-by-count":24,"title":["<i>LRRK2<\/i>\n                    -associated parkinsonism with and without\n                    <i>in vivo<\/i>\n                    evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization"],"prefix":"10.1093","volume":"7","author":[{"given":"Lana M","family":"Chahine","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Pittsburgh , Pittsburgh, PA 15213 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David-Erick","family":"Lafontant","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Iowa , Iowa City, IA 55848 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Iowa , Iowa City, IA 55848 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Iwaki","sequence":"additional","affiliation":[{"name":"DataTecnica LLC , Washington, DC 20037 ,","place":["USA"]},{"name":"Center for Alzheimer\u2019s and Related Dementias, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute on Aging, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Laboratory of Neurogenetics, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9358-8111","authenticated-orcid":false,"given":"Cornelis","family":"Blauwendraat","sequence":"additional","affiliation":[{"name":"Center for Alzheimer\u2019s and Related Dementias, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute on Aging, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Laboratory of Neurogenetics, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B","family":"Singleton","sequence":"additional","affiliation":[{"name":"Center for Alzheimer\u2019s and Related Dementias, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute on Aging, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute of Neurological Disorders and Stroke, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Laboratory of Neurogenetics, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Brumm","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Iowa , Iowa City, IA 55848 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy N","family":"Alcalay","sequence":"additional","affiliation":[{"name":"Tel Aviv Sourasky Medical Center , 64239 Tel-Aviv ,","place":["Israel"]},{"name":"Department of Neurology, Columbia University Irving Medical Center , New York, NY 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Merchant","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Nicole Holohan","family":"Nudelman","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Indiana University , Indianapolis, IN 46202 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0945-5779","authenticated-orcid":false,"given":"Alain","family":"Dagher","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute, McGill University , Montreal, QC , H3A 2B4","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vo","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute, McGill University , Montreal, QC , H3A 2B4","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tao","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute, McGill University , Montreal, QC , H3A 2B4","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S","family":"Venuto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Health and Technology, University of Rochester Medical Center , Rochester, NY 14642 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kieburtz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Health and Technology, University of Rochester Medical Center , Rochester, NY 14642 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L","family":"Poston","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stanford University School of Medicine , Palo Alto, 94304 CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bressman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine, Mount Sinai Beth Israel , New York City, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Gonzalez-Latapi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Avants","sequence":"additional","affiliation":[{"name":"Invicro, LLC , Needham, MA 02494 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Coffey","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health, University of Iowa , Iowa City, IA 55848 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Jennings","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc. , South San Francisco, CA 94080 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease & Movement Disorders Unit, Neurology Service, Hospital Cl\u00ednic de Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , 08036 Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas , 08028 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Siderowf","sequence":"additional","affiliation":[{"name":"Department of Neurology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Marek","sequence":"additional","affiliation":[{"name":"Institute for Neurodegenerative Disorders , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Simuni","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Parkinson\u2019s Progression Markers Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Simuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Siderowf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanne","family":"Dobkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Foroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kieburtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frasier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohini","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Videnovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Tosun-Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekemini","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seibyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Standaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Mantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Dahodwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwarzschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Marras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Shoulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Rowbotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Casalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Eberling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Kopil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"McGuire Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawny","family":"Willson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Flagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Fabrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixie","family":"Ecklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevis","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hobbick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena","family":"Antonopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Caspell-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Toga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Montine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseann","family":"Dobkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Korell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Espay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Factor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fullard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ching","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejko","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jose Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Moukheiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Noyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Njideka","family":"Okubadejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pavese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Postuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulietta","family":"Riboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Ruffrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ruiz Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie H","family":"Saint-Hilaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Schlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Shill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Tarakad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"7","key":"2025032523084816900_fcaf103-B1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.24962","article-title":"The neuropathology of genetic Parkinson's disease","volume":"27","author":"Poulopoulos","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"2025032523084816900_fcaf103-B2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurol"},{"issue":"11","key":"2025032523084816900_fcaf103-B3","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov Disord"},{"issue":"5","key":"2025032523084816900_fcaf103-B4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity and disease onset in the Parkinson\u2019s Progression Markers Initiative (PPMI) cohort using the \u03b1-synuclein seed amplification assay: A cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"issue":"6","key":"2025032523084816900_fcaf103-B5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/acn3.51776","article-title":"LRRK2 and Parkinson\u2019s disease: From genetics to targeted therapy","volume":"10","author":"Sosero","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"2025032523084816900_fcaf103-B6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: Challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat Rev Neurol."},{"issue":"3","key":"2025032523084816900_fcaf103-B7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/ijms22031045","article-title":"Genetic and environmental factors influence the pleomorphy of LRRK2 parkinsonism","volume":"22","author":"Chittoor-Vinod","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2025032523084816900_fcaf103-B8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/mds.29449","article-title":"Patterns of TDP-43 deposition in brains with LRRK2 G2019S mutations","volume":"38","author":"Agin-Liebes","year":"2023","journal-title":"Mov Disord"},{"issue":"12","key":"2025032523084816900_fcaf103-B9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"Establishing a Parkinson\u2019s disease biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"2025032523084816900_fcaf103-B10","volume-title":"The Hopkins verbal learning test-revised","author":"Brandt","year":"2001"},{"issue":"6","key":"2025032523084816900_fcaf103-B11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archneur.1978.00500300038006","article-title":"Visuospatial judgment. A clinical test","volume":"35","author":"Benton","year":"1978","journal-title":"Arch Neurol."},{"issue":"2","key":"2025032523084816900_fcaf103-B12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107319119900600204","article-title":"Norms for letter and category fluency: Demographic corrections for age, education, and ethnicity","volume":"6","author":"Gladsjo","year":"1999","journal-title":"Assessment"},{"issue":"16):","key":"2025032523084816900_fcaf103-B13","first-page":"e1691","article-title":"Updated percentiles for the university of Pennsylvania smell identification test in adults 50 years of age and older","volume":"100","author":"Brumm","year":"2023","journal-title":"Neurology"},{"issue":"8","key":"2025032523084816900_fcaf103-B14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/mds.28549","article-title":"Accelerating medicines partnership: Parkinson\u2019s disease. Genetic resource","volume":"36","author":"Iwaki","year":"2021","journal-title":"Mov Disord"},{"key":"2025032523084816900_fcaf103-B15"},{"issue":"12","key":"2025032523084816900_fcaf103-B16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"issue":"4","key":"2025032523084816900_fcaf103-B17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","article-title":"Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid","volume":"18","author":"Concha-Marambio","year":"2023","journal-title":"Nat Protoc"},{"key":"2025032523084816900_fcaf103-B18","first-page":"ppmi-infoorg","article-title":"Detection of \u03b1-synuclein oligomers in CSF using the 24\u2005h seed amplification assay (SAA)","volume":"237","author":"Concha-Marambio","year":"2024","journal-title":"PPMI Project ID"},{"issue":"12","key":"2025032523084816900_fcaf103-B19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","article-title":"Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: A multicentre cohort study","volume":"23","author":"Ma","year":"2024","journal-title":"Lancet Neurol"},{"issue":"5","key":"2025032523084816900_fcaf103-B20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2025032523084816900_fcaf103-B21","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"10","key":"2025032523084816900_fcaf103-B22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1515\/cclm-2016-1061","article-title":"Accuracy of cerebrospinal fluid A\u03b21-42 measurements: Evaluation of pre-analytical factors using a novel Elecsys immunosassay","volume":"55","author":"Rozga","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2025032523084816900_fcaf103-B23","first-page":"698","article-title":"Derivation of cutoffs for the Elecsys(\u00ae) amyloid \u03b2 (1-42) assay in Alzheimer's disease","volume":"10","author":"Shaw","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2025032523084816900_fcaf103-B24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"2025032523084816900_fcaf103-B25","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1038\/s41598-019-54204-z","article-title":"Predicting clinical decline and conversion to Alzheimer\u2019s disease or dementia using novel Elecsys A\u03b2(1-42), pTau and tTau CSF immunoassays","volume":"9","author":"Blennow","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"2025032523084816900_fcaf103-B26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JPD-212989","article-title":"Appropriateness of applying cerebrospinal fluid biomarker cutoffs from Alzheimer's disease to Parkinson\u2019s disease","volume":"12","author":"Weinshel","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"2025032523084816900_fcaf103-B27","doi-asserted-by":"crossref","first-page":"e208033","DOI":"10.1212\/WNL.0000000000208033","article-title":"Evaluation of ATN(PD) framework and biofluid markers to predict cognitive decline in early Parkinson disease","volume":"102","author":"Cousins","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"2025032523084816900_fcaf103-B28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-023-00468-2","article-title":"LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts","volume":"9","author":"Merchant","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"2025032523084816900_fcaf103-B29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/aje\/kwp425","article-title":"Multiple imputation for missing data: Fully conditional specification versus multivariate normal imputation","volume":"171","author":"Lee","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"12","key":"2025032523084816900_fcaf103-B30","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov Disord"},{"issue":"1","key":"2025032523084816900_fcaf103-B31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s40478-021-01276-6","article-title":"Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"9","author":"Brockmann","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"2025032523084816900_fcaf103-B32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.29284","article-title":"Brain and cerebrospinal fluid alpha-synuclein real-time quaking-induced conversion identifies Lewy body pathology in LRRK2-PD","volume":"38","author":"Garrido","year":"2023","journal-title":"Mov Disord"},{"issue":"1","key":"2025032523084816900_fcaf103-B33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-022-01388-7","article-title":"Performance of \u03b1-synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease","volume":"10","author":"Hall","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"2025032523084816900_fcaf103-B34","doi-asserted-by":"crossref","first-page":"1193458","DOI":"10.3389\/fmolb.2023.1193458","article-title":"Misfolded alpha-synuclein detection by RT-QuIC in dementia with Lewy bodies: A systematic review and meta-analysis","volume":"10","author":"Pe\u00f1a-Bautista","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2025032523084816900_fcaf103-B35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mds.29665","article-title":"Misfolded \u03b1-synuclein seeding is detected in suspected LRRK2-Parkinson\u2019s disease without immunohistochemically detectable \u03b1-synuclein pathology","volume":"39","author":"Kim","year":"2024","journal-title":"Mov Disord"},{"issue":"3","key":"2025032523084816900_fcaf103-B36","first-page":"217","article-title":"Genetic neuropathology of Parkinson\u2019s disease","volume":"1","author":"Cookson","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"issue":"1\u20132","key":"2025032523084816900_fcaf103-B37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2008.02.010","article-title":"Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration","volume":"270","author":"Gaig","year":"2008","journal-title":"J Neurol Sci"},{"key":"2025032523084816900_fcaf103-B38","doi-asserted-by":"crossref","first-page":"1204104","DOI":"10.3389\/fneur.2023.1204104","article-title":"Sex differences in alpha-synucleinopathies: A systematic review","volume":"14","author":"Raheel","year":"2023","journal-title":"Front Neurol"},{"key":"2025032523084816900_fcaf103-B39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fnagi.2018.00283","article-title":"Clinical heterogeneity among LRRK2 variants in Parkinson's disease: A meta-analysis","volume":"10","author":"Shu","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"2025032523084816900_fcaf103-B40","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/acn3.489","article-title":"Sex differences in LRRK2 G2019S and idiopathic Parkinson's disease","volume":"4","author":"San Luciano","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"2025032523084816900_fcaf103-B41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2019.05.028","article-title":"Sex differences in mixed neuropathologies in community-dwelling older adults","volume":"1719","author":"Barnes","year":"2019","journal-title":"Brain Res"},{"issue":"7","key":"2025032523084816900_fcaf103-B42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp-2020-325668","article-title":"Sex differences for phenotype in pathologically defined dementia with Lewy bodies","volume":"92","author":"Bayram","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2025032523084816900_fcaf103-B43","first-page":"e12016","article-title":"In vivo network models identify sex differences in the spread of tau pathology across the brain","volume":"12","author":"Shokouhi","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2025032523084816900_fcaf103-B44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2016.04.012","article-title":"Alzheimer, mitochondria and gender","volume":"67","author":"Grimm","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"2025032523084816900_fcaf103-B45","doi-asserted-by":"crossref","first-page":"110668","DOI":"10.1016\/j.brainresbull.2023.110668","article-title":"Impact of sex on neuroimmune contributions to Parkinson's disease","volume":"199","author":"Bourque","year":"2023","journal-title":"Brain Res Bull"},{"issue":"1","key":"2025032523084816900_fcaf103-B46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12974-016-0588-5","article-title":"Inflammatory profile in LRRK2-associated prodromal and clinical PD","volume":"13","author":"Brockmann","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2025032523084816900_fcaf103-B47","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/brain\/awad297","article-title":"Pleiotropy with sex-specific traits reveals genetic aspects of sex differences in Parkinson\u2019s disease","volume":"47","author":"Nordengen","year":"2023","journal-title":"Brain"},{"issue":"2","key":"2025032523084816900_fcaf103-B48","doi-asserted-by":"crossref","first-page":"fcab126","DOI":"10.1093\/braincomms\/fcab126","article-title":"Interactive rather than independent effect of APOE and sex potentiates tau deposition in women","volume":"3","author":"Wang","year":"2021","journal-title":"Brain Commun"},{"issue":"2","key":"2025032523084816900_fcaf103-B49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yhbeh.2012.05.013","article-title":"Risk factors for Parkinson\u2019s disease may differ in men and women: An exploratory study","volume":"63","author":"Savica","year":"2013","journal-title":"Horm Behav"},{"issue":"5","key":"2025032523084816900_fcaf103-B50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.27974","article-title":"Penetrance of Parkinson\u2019s disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score","volume":"35","author":"Iwaki","year":"2020","journal-title":"Mov Disord"},{"issue":"9","key":"2025032523084816900_fcaf103-B51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/acn3.95","article-title":"Olfactory identification in LRRK2 G2019S mutation carriers: A relevant marker?","volume":"1","author":"Saunders-Pullman","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"2025032523084816900_fcaf103-B52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","article-title":"Transfer of human \u03b1-synuclein from the olfactory bulb to interconnected brain regions in mice","volume":"126","author":"Rey","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2025032523084816900_fcaf103-B53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s40478-019-0859-3","article-title":"\u03b1-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb","volume":"7","author":"Rey","year":"2019","journal-title":"Acta Neuropathol Commun."},{"issue":"Pt B","key":"2025032523084816900_fcaf103-B54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","article-title":"The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases","volume":"109","author":"Rey","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2025032523084816900_fcaf103-B55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u2014Towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"2025032523084816900_fcaf103-B56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"2025032523084816900_fcaf103-B57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1567205020666230601123123","article-title":"Blood neurofilament light chain in different types of dementia","volume":"20","author":"Gu","year":"2023","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"2025032523084816900_fcaf103-B58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/biom13050845","article-title":"Overview of the impact of pathogenic LRRK2 mutations in Parkinson's disease","volume":"13","author":"Ito","year":"2023","journal-title":"Biomolecules"},{"key":"2025032523084816900_fcaf103-B59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000113460","article-title":"Autosomal dominant familial Parkinson disease: Older onset of age, and good response to levodopa therapy","volume":"38 Suppl 1","author":"Hasegawa","year":"1997","journal-title":"Eur Neurol"},{"issue":"4","key":"2025032523084816900_fcaf103-B60","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"2025032523084816900_fcaf103-B61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40478-018-0617-y","article-title":"Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations","volume":"6","author":"Takanashi","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"2025032523084816900_fcaf103-B62","doi-asserted-by":"crossref","first-page":"148.e17","DOI":"10.1016\/j.neurobiolaging.2020.07.002","article-title":"Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease","volume":"97","author":"Brown","year":"2021","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2025032523084816900_fcaf103-B63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.201798099","article-title":"Rab29 activation of the Parkinson's disease-associated LRRK2 kinase","volume":"37","author":"Purlyte","year":"2018","journal-title":"EMBO J"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaf103\/62298367\/fcaf103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/2\/fcaf103\/62298367\/fcaf103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/2\/fcaf103\/62298367\/fcaf103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:14:11Z","timestamp":1743221651000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaf103\/8056104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaf103","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.22.24310806","asserted-by":"object"}]},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"fcaf103"}}